🇺🇸 FDA
Patent

US 11155879

Method of predicting effects of CDC7 inhibitor

granted A61KA61K31/519A61P

Quick answer

US patent 11155879 (Method of predicting effects of CDC7 inhibitor) held by Takeda Pharmaceutical Company Limited expires Mon Oct 21 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Oct 26 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 21 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61K, A61K31/519, A61P, A61P35/00